Milestone underlines company’s global leadership in sample preparation Company’s NGS assays also hit milestone of one million samples tested since 2015 New kits and instruments will bolster QIAGEN’s ...
QIAGEN N.V. QGEN announced that it is working to develop a QIAstat-Dx test kit to distinguish the novel SARS-CoV-2 coronavirus from 21 other serious respiratory infections. The company also announced ...
Services will be carried out at WuXi’s facility in Shanghai with Qiagen’s technologies and training. Qiagen Asia Pacific and WuXi AppTec forged a pact to provide a single solution for molecular ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it will develop a new QIAstat-Dx test kit to differentiate the novel SARS-CoV-2 ...
HILDEN, Germany & GERMANTOWN, Md. & KOBE, Japan--(BUSINESS WIRE)--QIAGEN (NYSE:QGEN; Frankfurt Prime Standard:QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo ...
QIAGEN N.V. QGEN announced that it is working to develop a QIAstat-Dx test kit to distinguish the novel SARS-CoV-2 coronavirus from 21 other serious respiratory infections. The company also announced ...
First syndromic testing solution to get U.S. agency's development support in novel coronavirus response QIAstat-Dx Respiratory SARS-CoV-2 Panel test kit will rapidly differentiate novel coronavirus ...
Global strategic alliance to leverage Sysmex’s Plasma-Safe-SeqS technology QIAGEN will use ultra-sensitive liquid biopsy applications in oncology Alliance boosts QIAGEN’s co-development of companion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback